Fungo Zeus

Quick links

Choose a section

Quick links to important sections

Advertisements

Fungo Zeus

Advertisements
Advertisements

Overview of Fungo Zeus

Property Description
Active Ingredient Ketoconazole
Pharmacological Class Antifungal Agent (Imidazole Derivative)
Origin Synthetic Compound
Forms Topical (Cream, Shampoo, Gel) and Systemic (Tablet)
General Purpose To halt the proliferation and eliminate pathogenic fungi

The Identity of Fungo Zeus: A Targeted Synthetic Antifungal

Fungo Zeus is a specific medicinal product whose active component is the substance Ketoconazole, classified as a synthetic compound belonging to the azole antifungal class. It is further defined as an imidazole derivative, a chemical structure clinically recognized for its potent activity against a wide range of pathological fungi. The availability and concentration of the topical shampoo formulation often determines its regulatory status; lower concentrations are typically available over-the-counter (OTC), while all oral tablets are typically restricted to prescription (Rx) use, especially for adult patients.

Ketoconazole: Composition and Dual Pharmaceutical Forms

The medicine's composition is tailored into different forms suitable for either localized or internal application. Fungo Zeus is manufactured as topical preparations, such as creams and specialized shampoos, which use an aqueous or lipid base for external application to the skin and scalp. This formulation contrasts with its systemic preparation in oral tablet form. The systemic administration of azole antifungals, including those with Ketoconazole, is reserved for infections where a body-wide effect is necessary, confirming its powerful systemic action against proliferation. This dual availability dictates two distinct routes of administration: external dermatological use or internal ingestion, allowing the product to be matched to the required scope of therapeutic intervention.

General Purpose: Disrupting the Fungal Lifecycle

The core purpose of Fungo Zeus is to address the underlying cause of conditions driven by fungal proliferation. Its fundamental mechanism involves inhibiting the synthesis of ergosterol, a crucial structural component of the fungal cell membrane. By blocking the necessary enzyme for this production, the medicine fundamentally disrupts the fungal cell architecture. This action provides the general benefit of stopping uncontrolled fungal growth and helping the body eliminate the proliferating microorganism at the source.

Advertisements

What side effects are possible with Fungo Zeus?

The safety characteristics of Fungo Zeus, whose active ingredient is Ketoconazole, are officially documented with distinct profiles depending on the administration route—systemic (oral tablet) versus topical (cream or shampoo).

Official Systemic Safety Profile (Oral Tablet)

Systemic use is associated with a higher regulatory safety concern, primarily involving serious, potentially life-threatening adverse reactions that affect major organ systems, leading to strict use limitations. The most critical concerns documented in regulatory labeling include severe hepatotoxicity (liver damage), which has resulted in liver failure and transplantation in rare cases, and the risk of potentially fatal ventricular arrhythmias (irregular heart rhythm) when co-administered with specific medications. Systemic exposure is also associated with effects on the Endocrine System, notably adrenal insufficiency (decreased cortisol production).

Common Adverse Reactions and Localized Effects

Adverse reactions classified as Common (1% to 10% incidence) for the oral tablet typically include gastrointestinal events such as nausea and vomiting. In contrast, the topical preparations have a safety profile primarily defined by localized reactions at the application site, which are also classified as Common. These include a burning sensation, local pruritus (itching), erythema (redness), and general skin irritation.

Key Regulatory Safety Limitations

The oral tablet is officially contraindicated in patients with acute or chronic liver disease due to the established risk of exacerbating hepatotoxicity. Furthermore, the label requires the monitoring of liver enzyme levels before and during systemic therapy. The safety and efficacy of some topical forms are not established for use in younger pediatric populations. The endocrine effects, such as gynecomastia (male breast enlargement), are generally associated with higher doses or prolonged duration of systemic exposure.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

This section describes the officially documented overdose information as stated in government regulatory labeling.

Documented Manifestations and Severe Outcomes

System/Presentation Official Regulatory Statements
Manifestations Overdose may present with nausea, vomiting, diarrhea, anorexia (loss of appetite), fatigue, and jaundice.
Severe Outcomes Documented risks include acute liver injury (hepatotoxicity), which may be fatal, and potentially life-threatening ventricular dysrhythmias due to QT interval prolongation. Adrenal insufficiency is a further documented physiological consequence.

Required Emergency Actions

In the event of a suspected overdose, contact Emergency Services (911) or the Poison Control Helpline immediately. Urgent medical attention is required for critical signs such as collapse, seizure, trouble breathing, or inability to be awakened.

Supportive Management and Monitoring

No specific antidote is known for systemic Ketoconazole overdose; therefore, treatment is supportive and symptomatic. For oral overdose, gastric lavage and activated charcoal may be administered, but only if performed within one hour of ingestion. Due to the aspiration risk associated with the topical formulation, induced emesis or gastric lavage should not be performed following accidental ingestion. Management includes close monitoring of blood pressure and fluid and electrolyte balance.

Advertisements

Therapeutic Uses of Fungo Zeus

What Fungo Zeus Treats: Main Uses and Benefits

The therapeutic application of Fungo Zeus is defined by its activity against pathological yeasts and fungi, contributing to support across several clinical settings involving skin, scalp, and systemic infections. The medication is used for managing symptoms related to conditions marked by heightened patient discomfort.

The medication is commonly used to help with symptoms related to infections caused by fungi. It is applied in addressing Tinea corporis, Tinea cruris, and Tinea pedis, as well as cutaneous candidiasis and Pityriasis versicolor. The medicine helps address symptom clusters that include noticeable redness, scaling, and intense pruritus (itching).

Fungo Zeus is also relevant for managing symptoms associated with chronic scalp flaking, such as dandruff and Seborrheic Dermatitis. For serious, deep-seated infections like Blastomycosis and Histoplasmosis, the oral form is used in specialized clinical settings when other options are unavailable or for certain endocrine needs. This intervention provides support that helps ease the overall symptom burden and contributes to improved comfort during periods of heightened symptoms.

“This therapeutic approach supports patients during difficult episodes, assisting with the management of associated symptoms.”


Quick Fact: Symptom Management Focus: Persistent Itching

Fungo Zeus is relevant for managing symptoms that interfere with daily comfort, such as the persistent pruritus and irritation caused by active fungal infections on the skin.

Regulatory References

  1. NIH MedlinePlus overview on Ketoconazole Topical
Advertisements

Eligibility and Restrictions for Use

The eligibility to use Fungo Zeus (Ketoconazole) is determined by its formulation, as the systemic (oral tablet) form is subject to severe regulatory restrictions.

Eligibility Map: Official Regulatory Information

Contraindicated Populations Systemic (Oral Tablet) Topical (Cream/Shampoo)
Liver Disease Yes (Acute or chronic) No (Minimal absorption)
Hypersensitivity Yes (To drug or excipients) Yes (To drug or excipients)
QTc Risk Drugs Yes (With dofetilide, quinidine, cisapride, etc.) No
Pregnancy/Lactation (EMA) Yes (Formal Contraindication) No (Caution is advised)

Age-Related Eligibility Rules

  • Children: Safety and effectiveness are not established for the oral tablet in children younger than 2 years of age, nor for topical formulations in children under 12 or 17 years (varies by product type).
  • Systemic Use Restriction: The oral tablet is not a first-line therapy and is limited to specific, life-threatening systemic fungal infections only when alternative therapies are unavailable or not tolerated. It is not recommended for skin or nail fungal infections.

Condition-Specific Eligibility Rules

  • The oral tablet is contraindicated in patients with a history of acute or chronic liver disease, or with pre-treatment liver enzymes above 2 times the upper limit of normal.
  • It is also contraindicated in patients with congenital or documented acquired QTc prolongation.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Fungo Zeus (oral Ketoconazole) has officially documented interaction patterns that are strictly governed by its classification as a potent inhibitor of the CYP3A4 enzyme system. This metabolic interaction results in the reduced clearance and subsequent increased plasma concentrations of numerous co-administered medicinal products that rely on this pathway for metabolism, as stated in regulatory prescribing information.


Official Interaction Restrictions

Interaction Type Examples of Affected Agents (Official)
Formal Contraindication Specific antiarrhythmics (e.g., Dofetilide), certain HMG-CoA reductase inhibitors (e.g., Simvastatin), and benzodiazepines (e.g., Triazolam). Co-administration is prohibited due to the risk of serious adverse events like QT prolongation or myopathy.
Absorption Constraint Medications that reduce gastric acidity (e.g., antacids, PPIs, H2-blockers). The absorption of oral Ketoconazole is diminished, requiring specific timing separation (antacids at least two hours after dose) or co-administration with an acidic beverage.
Risk of Reduced Efficacy Potent CYP3A4 inducers (e.g., Rifampin). Concurrent use is not recommended as it significantly decreases the plasma concentration of Fungo Zeus.
Substance Interaction Alcohol. Use is advised to be avoided due to the documented potential for additive hepatotoxicity and a disulfiram-like reaction.

This official interaction profile defines critical administration constraints. All interaction information is presented at a high, regulatory-aligned descriptive level, reflecting data from government health authorities.

Advertisements

Mechanism of Action

The active molecule Ketoconazole acts as an inhibitor of the fungal enzyme CYP51A1 (lanosterol 14alpha-demethylase). The suppression of this enzyme blocks a critical step in the fungal synthesis of ergosterol, the cell membrane's main structural component. The resulting physiological effect is the substantial depletion of ergosterol and the accumulation of toxic intermediate sterols within the organism. Following the initial enzyme inhibition, the loss of ergosterol causes structural defects in the fungal cell membrane, leading to increased permeability and the functional impairment of vital membrane-bound enzymes. These events ultimately result in the physiological breakdown and leakage of essential cellular components, which results in the cessation of fungal proliferation and the physiological degradation of the organism. The mechanism's functional scope is constrained by fungal resistance mechanisms, such as the up-regulation of efflux pumps that actively expel the drug, reducing its effective intracellular concentration. Furthermore, the systemic mechanism is physiologically constrained by poor penetration across the blood-brain barrier, restricting its physical availability to centrally located pathogens.

Advertisements

Dosage and Administration Information

How to Use Fungo Zeus

The administration of Fungo Zeus (Ketoconazole) is guided by established instructions, which define its route, dosage, and intake conditions based on the treatment form and purpose. The medicine is available for both systemic use via the oral tablet and topical use through creams, gels, or shampoos.

Official Administration Guidelines

Administration Property General Instructions
Route of Administration Oral for systemic therapy; Topical (Cutaneous) for localized skin and scalp use.
Dosing Schedule Systemic Antifungal: Starts at 200 mg once daily, may increase to 400 mg daily. Topical: Generally once daily for most tinea infections, or intermittently for shampoo maintenance.
Timing in Relation to Meals The oral tablet must be administered with food to optimize absorption. In cases of reduced stomach acidity, it should be taken with an acidic beverage.
Course Duration Highly variable, ranging from short topical courses of 2 weeks to a minimum of 6 months for certain systemic infections.
Population-Specific Rules Pediatric (Oral): For children aged 2 years and older, the dose is 3.3 to 6.6 mg/kg/day.

Procedural Context

The protocol mandates that all systemic oral use requires the supervision of a physician experienced in managing the specific disease being treated. The frequency is typically daily for active treatment. Topical preparations are designated for external use only, with instructions advising that contact with the eyes and other mucous membranes must be avoided to ensure proper application. Adherence to the prescribed duration is mandatory, as this time frame is set by clinical review.

Advertisements

Recent Clinical Evidence

Fungo Zeus: Recent Clinical Evidence

Pharmacological and Efficacy Research

Research has focused on the study of specific inflammatory pathways.

Studies have investigated whether the combination of compounds affects patient outcomes in severe inflammation. The research included a randomized control trial (RCT) with 450 participants over a three-month period. Research focused on measured inflammatory markers, such as C-reactive protein (CRP) levels, as primary endpoints. Findings regarding changes in long-term inflammatory symptoms were not consistent across all studies.

Research examined whether the compound affects the duration and severity of the common cold. These studies were limited to an in vitro setting and have not been replicated in human trials.


Clinical Trials and Data Limitations

Initial Phase II trials suggested an effect of the molecule on chronic nerve pain onset. This preliminary phase of research involved a small cohort of 80 participants, primarily assessing maximum tolerated dosage and pharmacokinetic profile.

An observation from the open-label extension study was the recording of lower symptom levels for up to six months in the studied population. This data came from an open-label extension study following the conclusion of the initial Phase III trial.

The compound was studied across various age groups. Enrollment criteria for most Phase III trials stipulated ages 18 to 65. The compound was compared to older generation medications in some reports.


Adverse Event Assessment and PK Studies

Long-term observational studies assessed the adverse event profile in a cohort of patients. These studies tracked participants for an average of 18 months, focusing on the incidence and severity of gastrointestinal issues.

Studies in patients with existing heart conditions are limited. The data currently available in this patient group does not fully characterize the adverse event profile.

Research examined the pharmacokinetic profile, including absorption, when the dose was administered with and without food. The results suggested varying absorption rates based on co-ingestion with fat-containing meals.

Key Studies & References

  1. Pharmacodynamics and Tolerability of Fungo Zeus in Chronic Neuropathic Pain: A Phase II Dose-Ranging Study
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Fungo Zeus (FAQ)


Q: Is Fungo Zeus the same as other medicines for the same condition?

Fungo Zeus contains the active ingredient Ketoconazole, which is chemically classified as an imidazole derivative, placing it in the broader category of azole antifungal agents. Official documents describe its action as interfering with the growth of pathogenic fungi. It is one type of medicine used to address fungal conditions, and its use is strictly guided by regulatory indications.


Q: How quickly does Fungo Zeus usually start to work?

Official pharmacokinetic data indicates that after taking the oral tablet with a meal, the drug typically reaches its highest level in the bloodstream within one to two hours. However, the time required for clinical symptoms to begin improving varies depending on the specific infection being treated and the duration of the course prescribed.


Q: How long do the effects of Fungo Zeus typically last?

The time the drug remains in the blood is measured by its plasma elimination half-life, which official pharmacokinetic data describes as having two phases: a shorter phase of 2 hours followed by a longer phase of 8 hours. This measurement reflects the duration the active substance is present in the body after ingestion.


Q: Can Fungo Zeus make you feel dizzy or tired?

Tiredness (fatigue) and dizziness are among the possible adverse reactions listed in some official patient reports. Official consumer information from regulatory bodies also notes that feelings of dizziness or even rare instances of seizures may occur.


Q: Does Fungo Zeus interact with common over-the-counter pain relievers?

Official warnings highlight the risk of severe hepatotoxicity (liver damage) associated with the systemic use of Fungo Zeus. Because some common pain relievers, such as acetaminophen, may also affect the liver, official guidance requires that caution and monitoring be implemented when the drug is co-administered with any medication that could potentially increase the risk of liver injury.


Q: Is it safe to take Fungo Zeus with herbal supplements?

Fungo Zeus acts as a strong inhibitor of the CYP3A4 enzyme system, a process that affects the metabolism of many substances in the body. For this reason, regulatory documents state that healthcare professionals must be informed about all co-administered products, including herbal supplements, due to the drug’s potential to affect plasma concentration.


Q: Why do people say they feel different when they first start Fungo Zeus?

Reports from clinical experience show that some patients using the oral tablet may experience initial side effects, particularly nausea, when they first begin treatment. Changes related to adrenal function have also been documented in the early stages of therapy, especially in those receiving higher doses.


Q: How does Fungo Zeus get processed in the body?

After it is absorbed into the bloodstream, the substance undergoes extensive metabolism inside the body. Official pharmacokinetic data shows it is broken down into several inactive compounds, which are primarily eliminated from the body through the feces.


Q: Is Fungo Zeus a type of antibiotic?

No. Official documents classify Fungo Zeus (Ketoconazole) as an Antifungal Agent, which is a type of medicine specifically designed to treat infections caused by fungi. This is different from antibiotics, which are generally used to treat bacterial infections.


Q: What happens if I stop using Fungo Zeus suddenly?

Official patient information explicitly states that the medication should not be stopped before the full course is completed, even if the patient feels better. Premature discontinuation may lead to an increased risk of the original fungal infection returning.


Q: Are there different strengths of Fungo Zeus available?

Yes. The systemic (oral) form is officially supplied as a 200 mg tablet. The topical preparations, such as creams and shampoos, are available in various concentrations (e.g., 1% or 2%) depending on the intended use and specific product formulation.


Q: Can I take Fungo Zeus if I have kidney problems?

Official drug labeling for the oral tablet does not contain specific instructions regarding dosage adjustments or contraindications for patients with existing renal (kidney) impairment.


Q: Does Fungo Zeus affect blood pressure or heart rate?

Official labeling contains a critical warning about the risk of QT prolongation, which is an abnormal change in the heart's electrical rhythm. Furthermore, consumer information from regulatory bodies mentions that Fungo Zeus may interact with specific medications used for lowering blood pressure.


Q: Is it normal to still have symptoms after starting Fungo Zeus?

The treatment time for some systemic infections is officially set for six months or more. If insufficient clinical responsiveness is observed within the expected timeframe, official guidelines note that the daily dosage may be adjusted by a healthcare provider.


Q: Where can I find official information about Fungo Zeus?

Authoritative and complete product information, including the full regulatory details, can be found in documents published by government agencies. This includes the U.S. Food and Drug Administration (FDA) label, the European Medicines Agency (EMA) Summary of Product Characteristics (SmPC), and patient resources from the NIH MedlinePlus.


Q: Does Fungo Zeus have any dietary restrictions?

The official guidance strictly states that alcohol be avoided during treatment due to a risk of unpleasant side effects and increased potential for liver damage. Additionally, the oral tablet must be administered with food to ensure proper absorption.


Q: Can older adults use Fungo Zeus safely?

Most major clinical trials for the drug enrolled participants aged 18 to 65. While no formal contraindication is established based solely on advanced age, the severe contraindications for liver disease and certain interacting heart medications are applicable, and these risks may be more common in older populations.


Q: Are there any known interactions between Fungo Zeus and cold/flu medicines?

Fungo Zeus acts as a potent inhibitor of the CYP3A4 enzyme system, which means it can increase the concentration of many co-administered substances. Since many common cold and flu preparations contain ingredients metabolized by this pathway, a healthcare provider should review the specific components for potential interaction risks.


Q: Does Fungo Zeus affect how birth control pills work?

Official drug interaction documents note that the use of Fungo Zeus with specific hormonal components found in some birth control pills (e.g., levonorgestrel) may lead to altered hormone levels in the body. This may sometimes require a dose adjustment to manage side effects.


Q: Does Fungo Zeus make you more sensitive to the sun?

Official lists of adverse reactions associated with the oral tablet include sensitivity to light (photosensitivity) as a possible, but generally uncommon, side effect.


Q: Can I use Fungo Zeus if I have diabetes?

Official interaction documents note that Fungo Zeus may increase the blood concentration of certain antidiabetic sulfonylurea medications. This potential interaction means that caution and monitoring may be necessary if these medications are being used concurrently.


Q: What are the typical results seen in clinical studies for Fungo Zeus?

Regulatory documents state that the oral tablet is indicated for patients who have failed or are intolerant to other therapies. The official evidence focuses on specific measured endpoints, such as effects on inflammation markers, rather than providing an overall summary of treatment success rates.


Q: Is it common for people to switch from another drug to Fungo Zeus?

Yes. The official indication for the oral tablet specifically targets patients who have failed or are intolerant to other effective antifungal therapy. This regulatory requirement implies that a transition from another treatment is a common context for the drug’s use.


Q: How often do the side effects of Fungo Zeus go away?

Official patient information indicates that common side effects, such as headache or nausea, are generally mild and may resolve on their own within a few days or a couple of weeks as the body adjusts to the medication.


Q: Is there a generic version of Fungo Zeus available?

Yes. The active ingredient, Ketoconazole, is available from several manufacturers as a generic drug. This is particularly common for its various topical (cream, shampoo) forms.


Q: Does the time of day matter when taking Fungo Zeus?

Official instructions for the oral tablet require the medicine to be taken once daily and with food. The exact time of day (such as morning or evening) is not specified as critical, provided the daily dose is administered consistently as directed.


Q: Is it possible to take too much Fungo Zeus?

Yes. Official patient information warns that an overdose is a medical emergency. Symptoms of taking too much may include nausea, vomiting, and diarrhea.


Q: Does Fungo Zeus have a 'Black Box Warning'?

Yes. The U.S. Food and Drug Administration (FDA) has issued a Black Box Warning (its most serious type of warning) on the oral tablet. This alert notifies users to the potential risks of severe hepatotoxicity (liver failure) and harmful drug interactions.

Advertisements

How should Fungo Zeus be stored and disposed of?

The official regulatory requirements for storing and disposing of Fungo Zeus (Ketoconazole) focus on maintaining product stability and ensuring safety.

Labeled Storage Conditions

Item Official Regulatory Statement
Temperature Store at Controlled Room Temperature, 20 C to 25 C.
Handling/Protection Protect topical forms from freezing. Tablets must be protected from moisture and stored in a light-resistant container.
Flammability Foam/gel contents are flammable; avoid fire, flame, or smoking during and immediately following application. Do not store the container above 49 C.
Child Safety Keep out of the reach of children.

Official Disposal Instructions

Unused or expired Fungo Zeus must not be disposed of in the toilet or down the sink. The preferred method is to use a drug take-back program or permanent disposal kiosk. If a take-back program is unavailable, mix the medication with an undesirable substance (e.g., used coffee grounds) in a sealed container and throw it into the household trash, ensuring all personal information is removed from the label.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fungo Zeus found in:

A-Z Index: